RE: Updates appreciated everyone17 Oct 2016 21:55
I think you're correct with the 3rd option, a canny BOD.
I think the initial intention was obvs to invest 75% in resource but when the opportunity came along in N4, the BOD's heads were turned in the direction of the pharma sector.
I think most of us are here for N4 and Gavin B / Luke C are no different in their assessment of the company and its huge potential. As you say, they've known for ages that the policy would not be fulfilled and that is why I think this situation has been engineered by them.
I haven't a clue how difficult / what the process would be to amend an existing investment policy, so maybe it is just easier in this instance to suspend and then RTO. Maybe the 2nd investment that was mentioned in the 1/2 yr report was also a medical/biotech one and therefore the BOD knew a new investment direction was required...?
As people have mentioned NT has 16% worth over 400k. He must be privy to the goings on and would have given his blessing that this situation was best in the short term going forward and necessary for the future advancement of both N4 and ONZ..
All just my assumptions / thinking aloud...Who knows what will happen but I am confident of a positive outcome for us all.